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Diabeticpolyneuropathy(DPN)andcold-inducednerveinjuryshareseveralpathogenicmechanisms.Thisstudyexploreswhether
cold exposure contributes to the development of DPN. Streptozotocin-induced diabetic rats and controls were exposed to a room
temperature (23
◦C) or cold environment (10
◦C). H-reﬂex, tail and sciatic motor, and sensory nerve conduction studies were
performed.Analysesofsuralnerve,intraepidermalnerveﬁbers,andskinandnervenitrotyrosineELISAswereperformed.Diabetic
animals exposed to a cold environment had an increased H-reﬂex four weeks earlier than diabetic room temperature animals
(P = .03). Cold-exposed diabetic animals also had greater reduction in motor conduction velocities at 20 weeks (P = .017),
decreased skin nerve ﬁber density (P = .037), and increased skin nitrotyrosine levels (P = .047). Cold exposure appears to hasten
the development of DPN in the rat STZ model of diabetes. These ﬁndings support that further study into the relationship between
ambient temperature and DPN is warranted.
Copyright © 2009 Lora J. Kasselman et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
In humans, brief periods of intense cold exposure can be tol-
erated without adverse consequences, though prolonged or
repeated cold exposure can produce permanent nerve injury
[1]. First described in ancient times, cold-induced pathology
continues to be common, especially during times of war [2].
In addition, cold exposure can occur during normal daily
activities such as being outdoors during the winter months.
Even short exposures to mildly cold temperatures can reduce
skin temperature in the periphery [3]. The mechanisms
of cold-induced nerve injury are mainly ischemic, and
include slugging of blood due to decreased velocity [4] and,
with repeated exposure, reactive oxygen species formation
[5]. However, more mild cold exposure can also impair
other normal processes such as axonal transport [6, 7]a n d
exacerbate potentially detrimental processes such as protein
kinase C activation [8].
Many of these same mechanisms are also considered to
be important in the pathogenesis of diabetic polyneuropathy
(DPN) [9]. In particular, one area of overlap between cold
exposure and diabetes is the increased susceptibility of
diabetic nerves to ischemic damage [10, 11]. Because of these
shared potential mechanisms, it is plausible that exposure to
cold could enhance or perhaps accelerate the development of
DPN, and that intentional warming of the distal extremities
could protect against its development [12]. The implications
of such a connection would be important since it could
lead to new nonpharmacologic approaches toward slowing
the development of DPN, substantially impacting diabetic
patient care.
Whereas human epidemiological studies could help
address this question, animal models may also provide a
straightforward means for assessing the power of such an
association. Here we report the results of a study evaluating
the eﬀects of repeated periods of cold exposure on the2 Experimental Diabetes Research
development of DPN in the streptozotocin-(STZ-)induced
diabetic rat.
2.MaterialsandMethods
2.1. Animals and Induction of Diabetes. A total of 26 male
Wistar rats (300–350g; Charles River Laboratories, Wilm-
ington, MA, USA) were acclimated for one week prior to
experiments on a 12:12 hour light/dark cycle (lights on
07:00) and allowed food and water ad libitum. All of the
following procedures were approved by Beth Israel Dea-
coness Medical Center’s Institutional Animal Care and Use
Committee and followed the National Institutes of Health’s
(NIH) “Principles of laboratory and animal care” guidelines.
Streptozotocin (STZ; Fisher Scientiﬁc, Houston, TX,
USA) was injected into the tail vein of 12 rats, 10–12 weeks
old, at a dose of 55mg/kg body weight. The other 14 age-
matched rats received an equal volume of sterile phosphate
buﬀered saline. Forty-eight hours after injection of STZ,
blood glucose levels were tested to conﬁrm diabetes using a
commercially available blood glucose kit (Fisher Scientiﬁc,
Houston,TX,USA),andweremonitoredonceweeklyduring
the experiment. In addition to blood glucose, weight was
measured weekly and hemoglobin A1c (HbA1c)v a l u e sw e r e
determined twice during the study period. All animals were
conﬁrmed diabetic (plasma glucose levels of >250mg/dL) 1
weekafterSTZinjection.Followingconﬁrmationofdiabetes,
both diabetic and nondiabetic groups were each divided
into two groups: one to be exposed to cold and the other
to be exposed to room temperature. Exposure to these
two environments began within one week of diabetes being
successfully induced. Thus, this study had the following 4
groups: nondiabetic room temperature (n = 7), nondiabetic
cold (n = 7), diabetic room temperature (n = 6), and
diabetic cold (n = 6).
2.2. Cold Exposure. Chambers adapted from studies of cold
nociception were used for all temperature exposures [13].
A clear plexiglass perimeter wall (15cm high) was aﬃxed
to an aluminum plate (46 × 31 × 3cm) and divided into
six chambers by opaque black plexiglass dividers (15 ×
15cm per chamber) each of which would hold a single
animal. For cold exposure, the aluminum plate was cooled
to 10 ± 2◦C for 3 hours over an ice bath. This cold
temperaturerangewaschosenbecausepreliminarydatahave
suggested that normal human foot temperature can drop
into this range during outdoor winter activities (Rutkove,
unpublished results). More importantly, this represents a
temperature far above that considered likely to produce
permanent cold-injury (usually below 4◦C) [4].
The room temperature chamber was identical to the
one described above, but maintained at 23 ± 2◦Cf o r3
hours using a room temperature water bath. Both chambers
were constantly monitored with a diﬀerential thermocouple
thermometer (Product #15-077-26, Fisher Scientiﬁc, Pitts-
burgh, PA, USA) embedded in the aluminum plates. Using
this approach, ambient air temperature in the chambers
r e m a i n e db e t w e e n2 2a n d2 3
◦C but occasionally decreased
to 20
◦C during cold exposure. Animals were allowed to
move freely within their chambers and were exposed to
their respective conditions for approximately 3hours/day,
for 5days/week for 20 weeks. The 3-hour duration of cold
exposure was based upon the previous work assessing the
impact of nonfreezing cold on the rat sciatic nerve [4].
The 5 days per week frequency was chosen as a matter of
convenience and was reduced to 3-4 days if other tests (e.g.,
electrophysiology) were being performed on the animals in
the same week.
2.3. Animal Temperature Measurements. Core, paw, and tail
temperatures were measured before, during, and after expo-
sure periods using a calibrated thermocouple (Product #15-
077-26, Fisher Scientiﬁc, Pittsburgh, PA, USA). Paw temper-
ature measurements were taken by placing the thermocouple
probe between the 4th and 5th digits of the left hind paw.
Core temperatures were measured rectally. Tail temperatures
were measured by placing the probe on the proximal tail.
2.4. Electrophysiology. All electrophysiological measure-
ments were taken from both hind limbs on days when
the rats were not exposed to cold, with the rat limb
temperature carefully maintained at a minimum of 34
◦C
during testing using thermostatically controlled heating
blankets. Electrophysiological measurements were recorded
using a TECA Synergy T2 EMG Monitoring System and
TECA accessories (Viasys, Madison, WI, USA); a common
reference (ground) electrode was placed on the contralateral
limb. For all studies, supramaximal stimuli were applied and
velocities calculated from the onset latency of the recorded
potential. All sensory studies were digitally averaged until a
clear waveform was obtained.
2.4.1. Sensory and Motor Nerve Conduction Tests in the Tail.
For motor nerve conduction tests, a stimulating (cathode)
needle electrode was placed in two positions, the second
position 5cm proximal to the ﬁrst position. The recording
electrode was placed distally. Orthodromic sensory studies
were performed by employing the motor recording electrode
described above as the stimulating electrode and recording
with the more proximally placed motor stimulating elec-
trodes.
2.4.2. Sensory and Motor Nerve Conduction Tests in the Hind
Limb (Sciatic-Tibial Nerves). For motor nerve conduction
tests,acathodalneedleelectrodewasplacedintwopositions:
the ﬁrst position was at the sciatic notch and the second
position 3cm distally. The recording needle electrode was
placed in the foot. Orthodromic sensory studies were
performed by using the motor recording electrode described
aboveasthestimulatingelectrodeandrecordingatthesciatic
notch.
2.4.3. H-Reﬂex Recording from the Hind Paw. These studies
were performed on the sciatic-tibial nerve as previously
described [14]. Brieﬂy, a monopolar needle electrode was
placed subcutaneously on the medial aspect of the ankleExperimental Diabetes Research 3
and was used as the stimulating electrode. An anodal needle
electrode was placed proximally to the stimulating electrode
on the lateral aspect of the leg. Another monopolar needle
electrode was placed subcutaneously on the dorsomedial
aspect of the hindpaw and used as the active recording
electrode. A reference needle electrode was placed sub-
cutaneously in the proximal region of the tail. Stimulus
intensity was gradually increased until the H-reﬂex was at
maximum amplitude. The latency of H-reﬂexes, if present,
was recorded. Since the H-reﬂex is spinally mediated, the
depth of anesthesia was carefully monitored, and reduced if
necessary to assure the most robust response.
Electrophysiological measurements were conducted
before the induction of diabetes to determine baseline values
a n dr e p e a t e de v e r yo t h e rw e e kf o r2 0w e e k sf o rt a i lm o t o r
and sensory nerves as well as H-reﬂex. Sciatic-tibial nerve
conduction velocity was only conducted at one time point
in order to compare values obtained in this study with other
work in the literature.
2.5. Tissue Collection and Staining. Twenty weeks after
beginning cold and room temperature exposure, all animals
were given an overdose of chloral hydrate-pentobarbital
and exsanguinated with heparinized saline at 4◦C. Three
millimeter skin punch biopsies were taken from the right
hindpaws, lateral to the location of stimulating needle
electrode placement; a sural nerve biopsy was taken at
the calf level (the sural nerve was chosen over the sciatic-
tibial nerve given its more superﬁcial location and therefore
higher likelihood of showing cold-induced injury). Both
skin and nerve were postﬁxed in 2% paraformaldehyde-
lysine-periodate in Sorrenson’s buﬀer at 4◦C for histology.
Additional skin punch and sural nerve biopsies were taken
from the left hind paw and calf, respectively, and ﬂash
frozen for ELISAs. Animals were then perfused with 2%
glutaraldehyde, sural nerve tissue removed and post-ﬁxed
overnight at 4◦C. Skin biopsies were cut on a sliding
microtome at 50μm ,a n ds t o r e da t−20
◦C. Nerve sections
were cut on an ultramicrotome at 1μm and stained with
Toluidine Blue.
Skin sections were stained for PGP 9.5 using standard
immunostaining techniques [15]. Brieﬂy, sections were ﬁrst
incubated with rabbit-anti-PGP 9.5 (AbD Serotec, Raleigh,
NC, USA) at 1: 10,000 overnight, followed by a biotinylated
secondary antibody. The Vectastain Elite ABC immunoper-
oxidase kit (Vector Laboratories, Burlingame, CA, USA) and
diaminobenzidene were used for visualization and sections
were mounted using standard techniques.
2.6. Histological Quantiﬁcation. Skin. PGP 9.5-stained skin
sections were used to quantify intraepidermal nerve ﬁber
(IENF) density. Observers blind to treatment group identi-
ﬁed three areas of epidermis in three separate sections
per animal, resulting in nine total areas used for IENF
quantiﬁcation using a previously described approach [15].
Images were captured and epidermal length was analyzed
with the public domain NIH image program (http://rsb
.info.nih.gov/nih-image/). IENF density was calculated by
dividing the total number of ﬁbers counted per section by
the epidermal length of that section.
Sural Nerve. Toluidine Blue-stained nerve sections were
usedtoquantifyaxondensityaswellastheg-quotient,aratio
of axon thickness to total ﬁber thickness [16]; observers were
blindtotreatmentgroup.Astereologygrid(50 ×50μm)was
overlaid on top of images captured at 40X; only axons and
ﬁbers that fell under the line intersections were counted and
measured. Total nerve area, axon and ﬁber diameters were
calculated using the NIH image program mentioned above.
Brieﬂy, NIH image was calibrated using an image of a stage
micrometer with 10μm divisions taken at 40X. After line cal-
ibration, a straight line was used to measure axon diameter,
from the inside edges of the myelin sheath, and ﬁber diame-
ter,fromtheoutsideedgesofthemyelinsheath.Additionally,
the total number of axons that fell under the line intersec-
tions were counted and the total nerve area was calculated by
drawing a free-form line around the entire observable area
seenat40X.Axondensitywasquantiﬁedbydividingthetotal
number of axons counted by total nerve area.
2.7. Nitrotyrosine ELISA. Flash frozen skin and nerve tissue
were homogenized separately in lysis buﬀer. Total protein
content was determined for each sample using a bicin-
choninic acid (BCA) protein assay kit (ThermoScientiﬁc,
Rockford, IL, USA). Homogenized tissue, normalized by
total protein, was added to a nitrotyrosine coated 96-well
plate from a nitrotyrosine ELISA kit (Cell Bioloabs, Inc.,
San Diego, CA, USA), in duplicate for both skin and nerve,
and compared to nitrated bovine serum albumin standards.
Anti-nitrotyrosine primary and horseradish peroxidase con-
jugated secondary antibodies from the ELISA kit were used
at 1 : 1000. Results were read at 450nm and optical density
(OD) was used for statistical analysis.
2.8. Analysis. We analyzed all quantitative measures using
SPSS version 16.0 for Windows (SPSS, Chicago, IL, USA).
ANOVAs wereconductedataP ≤ .05signiﬁcancelevelusing
time as a repeated measure for weight, blood glucose levels,
foot temperature, and electrophysiological measurements.
For electrophysiological tests, no diﬀerence was detected
between the left and right hind limb measurements so all
analyses were conducted on data from the left side. Posthoc
tests were conducted when appropriate. Any analyses done
at a single time point (e.g., 20-week data and ELISA
measurements) were completed using an ANOVA without
time as a repeated measure. For histological analysis of skin
and nerve, a hierarchical linear model was conducted at a
P ≤ .05 signiﬁcance level using random terms for animals
a n ds e c t i o n sa n daﬁ x e dt e r mf o rt r e a t m e n t[ 17].
3. Results
3.1. Weight, Glucose, and HbA1c. Baseline measurements of
body weight, blood glucose, and HbA1c were similar among
all animals before random assignment to treatment groups.
However, after induction of diabetes by STZ injection,4 Experimental Diabetes Research
Table 1 :R a ts t a t u sa t2 0w e e k s .
Group Weight (g) Glucose (mg/dL) HbA1c (%)
mean ± SEM mean ± SEM mean ± SEM
Nondiabetic, room temperature (n = 7) 533 ± 14 125 ± 22 4.8 ± 0.3
Nondiabetic, cold-exposed (n = 7) 532 ± 14 125 ± 20 5.1 ± 0.3
Diabetic, room temperature (n = 6) 372 ± 16
∗ 345 ± 22
∗ 10.7 ± 0.3
∗
Diabetic, cold-exposed (n = 6) 379 ± 16
∗ 352 ± 22
∗ 10.9 ± 0.3
∗
∗P <. 0001 versus nondiabetic.
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Figure 1: H-reﬂex latencies and area under the curve. (a) Graph of H-reﬂex latencies shows diﬀerences among the treatment groups (open
circles = nondiabetic room temperature (n = 7), open squares = nondiabetic cold (n = 7), ﬁlled circles = diabeticroomtemperature(n = 6),
and ﬁlled squares = diabetic cold (n = 6)). At 10 weeks, diabetic animals exposed to a cold environment had a signiﬁcant increase in H-reﬂex
latency as compared to diabetic animals exposed to a room temperature environment, nondiabetic animals exposed to a cold environment,
and nondiabetic animals exposed to a room temperature environment. Mean ± SEM. #P = .03 versus all other groups.
∗P <. 05 versus
weeks 0–6. (b)Calculated areaunderthecurve(AUC)ofH-reﬂex latency from0 to10 weeks, derived fromFigure 1(a).Diabeticanimalshad
larger H-reﬂex latency AUCs than nondiabetic controls. Mean ± SEM.
∗∗P <. 001 for diabetes, $P = .025 for temperature, and #P = .042
for the interaction term. (c) Calculated AUC of H-reﬂex latency from 0 to 16 weeks derived from Figure 1(a). Although diabetic animals
in both groups (room temperature and cold) had greater AUCs than nondiabetic controls, the temperature and interaction eﬀects were no
longer apparent. Mean ± SEM.
∗∗P <. 001 versus nondiabetic controls.
diabetic animals did not gain weight, and remained sig-
niﬁcantly lighter than nondiabetic controls. In addition,
diabetic animals had a signiﬁcant increase in blood glucose
and HbA1c.T h e r ew a sn oe ﬀect of cold exposure on body
weight, blood glucose, or HbA1c (Table 1).
3.2. Electrophysiology. H-reﬂex latency was similar among
all animals at baseline. After 16 weeks, H-reﬂexes were
typically absent in diabetic animals and therefore only data
up to and including that time point were used for analysis.
Overall, diabetic animals had a signiﬁcantly longer H-reﬂex
latency than nondiabetic animals (P = .001; see Figure 1(a)).
In addition, after 10 weeks, diabetic animals exposed to
a cold environment had a signiﬁcantly longer H-reﬂex
latency as compared to diabetic animals exposed to a room
temperature environment and nondiabetic control animals
(P = .03; see Figure 1(a)), though while not signiﬁcant,
an increased latency in the diabetic cold animals couldExperimental Diabetes Research 5
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Figure 2: Tail and sciatic-tibial nerve conduction velocities. Graphs of sensory and motor nerve conduction velocities at 20 weeks show
diﬀerences among the treatment groups (control room temperature (n = 7), control cold (n = 7), diabetic room temperature (n = 6),
diabetic cold (n = 6)). (a) Diabetic animals (both room temperature and cold) had a signiﬁcant decrease in tail sensory nerve conduction
velocity as compared to nondiabetic control animals in both the room temperature and cold exposed groups. (b) Diabetic animals (both
room temperature and cold) had a signiﬁcant decrease in tail motor nerve conduction velocity as compared to nondiabetic control animals
in both the room temperature and cold exposed groups. Additionally, diabetic animals exposed to a cold environment had a modest
but signiﬁcant reduction in conduction velocity compared the diabetic animals not exposed to cold. (c) Diabetic animals (both room
temperature and cold) had a signiﬁcant decrease in sciatic-tibial motor nerve conduction velocity compared to nondiabetic control animals
in both the room temperature and cold exposed groups. Mean ± SEM.
∗∗P <. 001 versus nondiabetic control animals,
∗P = .007 versus
nondiabetic control animals, #P = .017 versus control room temperature and control cold exposed animals.
be seen as early as 8 weeks. In addition, at 10 weeks
after STZ treatment, diabetic animals exposed to a cold
environment had the largest H-reﬂex latency area under the
curve (AUC) from 0 to 10 weeks (P = .042; see Figure 1(b)).
However, by 16 weeks, diabetic animals exposed to a room
temperature environment had a similar H-reﬂex AUC as
diabeticanimalsexposedtoacoldenvironment(P = .86; see
Figure 1(c)), though both groups of diabetic animals had
larger AUCs than both nondiabetic control groups (P<
.001; see Figure 1(c)). There were no signiﬁcant changes in
the diabetic cold group compared to all other groups in any
other H-reﬂex parameters, for example, amplitude or area
(data not shown).
There were no diﬀerences in tail sensory or motor
nerve conduction velocities at baseline. Similar to H-reﬂex
latency, after treatment, both groups of diabetic animals
had signiﬁcant slowing of tail sensory nerve conduction
velocity (week 20 data shown; P<. 001; see Figure 2(a))a n d
tail motor nerve conduction velocity (week 20 data shown;
P = .004; see Figure 2(b)). Additionally, in the tail motor
nerve, diabetic animals exposed to cold had a subtle but
signiﬁcantreductioninconductionvelocityat20weeks(P =
.017; see Figure 2(b)).
In addition to tail nerve conduction, sciatic-tibial motor
and sensory nerve conduction velocities were measured at
one time point (16 weeks). Diabetic animals in both groups
(room temperature environment and cold exposed) had sig-
niﬁcantlyslowersciatic-tibialmotornerveconductionveloc-
ity than nondiabetic controls (P = .007; see Figure 2(c)),
but no diﬀerence was seen between the cold exposed- and
room temperature-diabetic groups. Similarly, nondiabetic
room temperature and cold-exposed animals had normal
sciatic-tibial sensory conduction velocities (53.3 +/− 4.0m/s
and 52.2 +/− 4.0m/s); diabetic room temperature animals
demonstrated mild slowing (48.9 +/− 4.6m/s) of conduc-
tion velocity; diabetic cold-exposed animals demonstrated
further slowing (46.5 +/− 4.6m/s), however none of these
diﬀerences were signiﬁcant.6 Experimental Diabetes Research
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Figure 3: Foot temperature measurements. Graphs of foot tem-
perature at room temperature and reduction in foot temperature
during environmental exposure (n = 7 each control group, n = 6
each diabetic group). (a) Foot temperature was higher in diabetic
rats, in both the room temperature and cold exposed groups,
when measured at room temperature. (b) During environmental
exposure, animals in the cold exposed groups (both nondiabetic
controls and diabetics) had the greatest decrease in foot tempera-
ture. Diabetic animals (both room temperature and cold exposed)
had a greater change in foot temperature compared to nondiabetic
controls; there was also a trend for the diabetic animals exposed to a
cold environment to have the greatest decrease in foot temperature
(P = .089). Mean ± SEM.
∗∗P <. 001 versus nondiabetic
controls,
∗P = .016 versus nondiabetic controls, $P <. 001 versus
room temperature.
3.3. Animal Temperature. There were no signiﬁcant diﬀer-
e n c e si nc o r et e m p e r a t u r e( P = .35) or tail temperature (P =
.52) among any groups after 20 weeks of treatment (data
not shown). However, after 20 weeks of treatment, diabetic
animals in both the room temperature and cold exposed
environments had a signiﬁcantly higher foot temperature
than controls, when measured at room temperature (P<
.001; see Figure 3(a)). Although diabetic animals had a
higher foot temperature than nondiabetic controls, both
diabetic and nondiabetic animals achieved the same foot
temperature when exposed to a cold environment (P = .54).
Thus, animals exposed to a cold environment (both diabetic
and nondiabetic control groups) showed a greater reduction
in foot temperature compared to animals in the room
temperaturegroupafterexposuretotheirrespectiveenviron-
ments (week 20 data shown; P<. 001; see Figure 3(b)). In
addition, diabetic animals in both temperature groups had
a larger change in temperature during the exposure periods
than nondiabetic controls (week 20 data shown; P = .016;
see Figure 3(b)).
3.4. Pathology. Sural Nerve. There were no signiﬁcant dif-
ferences in axon density (P = .40; data not shown) or g
quotients (P = .54; data not shown) among the four groups.
IENF Density. After 20 weeks of treatment, diabetic
animals exposed to a cold environment had the lowest IENF
density (P = .037; see Figure 4).
3.5. Nitrotyrosine ELISA. Sural Nerve. There were no signif-
icant diﬀerences in nitrotyrosine measurements among any
group (P = .20; data not shown).
Skin. After 20 weeks of treatment, diabetic animals
exposed to a cold environment had, on average, higher levels
of nitrotyrosine in the skin (diabetic cold = 3.11 OD versus
diabetic room temperature = 2.89, nondiabetic cold =
2.80, nondiabetic room temperature = 2.99; P = .047; data
not shown).
4. Discussion
This study provides early evidence for a subtle detrimental
eﬀe c to fr e p e a t e dc o l de x p o s u r eo nt h ep e r i p h e r a ln e r v e so f
diabetic rats, possibly through reactive oxygen species (ROS)
formation, as evidenced by elevated nitrotyrosine on skin
ELISA. Although standard motor and sensory conduction
studies in the tail and sciatic-tibial nerve revealed only small
diﬀerences between cold- and room temperature-exposed
animals, the H-reﬂex and IENF data are more suggestive.
Each of the major pathways considered potentially
causative of DPN may be enhanced by cold exposure. For
example, cooling and excessive temperature ﬂuctuations
havebeenshowntoenhanceproductionofROSinotherwise
healthy nerves. Constant cooling in the 10–12oCr a n g e
can increase ROS formation in normal rat nerves and
reduce the activity of glutathione, which is important in
the degradation of ROS [18]. In fact, increased levels of
ROS and decreased levels of glutathione lead directly to
decreased nerve conduction velocity [19, 20], supporting the
idea that increased ROS levels may account for the increased
H-reﬂex latency and the other electrophysiologic diﬀerences
observed. Unfortunately, we were not able to demonstrate
elevated levels of nitrotyrosine in the nerve to support
this concept; however, it is possible that other markers of
oxidative injury that were not measured were increased.
In contrast, we did identify elevated levels of nitrotyrosine
in the skin of diabetic cold animals, adding support to
the concept that ROS may be involved in intraepidermal
nerve ﬁber degeneration. This idea is also supported by
other work in which diabetic animals lacking poly (ADP-
ribose) polymerase, an enzyme believed to contribute toExperimental Diabetes Research 7
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Figure 4: PGP 9.5 stained skin and skin ﬁber density. Photomi-
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indicate PGP 9.5-positive ﬁbers. Mean ± SEM.
∗P = .037 for the
interaction term.
oxidative damage, did not show a decrease in skin nerve
ﬁbers compared to diabetic wild-type controls [21].
Animals exposed to intermittent cooling in the 1–5◦C
range experience rapid and severe block of neuronal conduc-
tion and edema in the myelin sheath of large neurons and
endoneurial blood vessels [22, 23]. Such changes are typical
ofthoseseeninnervetissueafterischemia-reperfusioninjury
[24] in which ROS formation plays a major role [25]. In
fact, diabetic animals are more susceptible to nerve damage
as a result of ischemic injury [10, 11], though typically
the mechanism of ischemia in animal models is acute and
severe (e.g., temporary ligation of major arteries in the
hindlimb). In the current study, repeated cold exposure may
have produced a mild form of chronic ischemia-reperfusion
injury, accounting for the increase in ROS observed. It is
of interest that other work, mainly in the realm of stroke
and spinal cord injury [26, 27] has shown that hypothermia
reduces ischemic-reperfusion injury. However, both the type
of injury (acute and severe) and type of cooling applied
(short-term) are quite diﬀerent from that studied in these
experiments in which cooling was continued for a period of
many weeks in the setting of a gradually progressive disease
process.
Although our studies did not employ such low temper-
atures in the 1–5◦C range, as described above, the results
of this study suggest the possibility that ROS could play
an important role at higher temperatures, especially in
susceptible diabetic nerves. Indeed, with exposure to more
mildcoolinginthe20
◦Crange,elevationsinplasmaviscosity
[28], red cell rigidity and volume [29], and reductions in
leukocyte mobility [30] are seen, leading to a reduction in
the rate of blood ﬂow through vessels. As a consequence of
reduced blood ﬂow, there is a slowing of oxygen delivery and
a reduction in the elimination of toxic metabolites. Similarly,
concentrations of endothelial-derived relaxing factors (e.g.,
nitric oxide, prostacyclin) and constricting factors (e.g.,
endothelin, angiotensin II), as well as blood vessel responses
to these factors, are also temperature dependent [31–33],
potentially leading to reduced blood ﬂow. Reduced axonal
transport also could play an important role. For example,
partial failure of fast axoplasmic transport occurs at a
temperature of 11
◦C, with slowing ensuing at considerably
higher temperatures [6]. Reductions in the rate of slow
and retrograde transport have also been demonstrated with
even relatively mild cooling (in the 14
◦Ct o3 0
◦Cr a n g e )
[7, 34, 35]. Finally, enhancement of protein kinase C activity
can also occur with cooling [8, 36].
These studies were performed at a variety of tempera-
tures, from as low as 1◦Ct oa sh i g ha s3 0
◦C. Our study
looked at the eﬀect of cooling only at 10 ± 2◦C, which is
relatively cold for human exposure during routine activities.
However, exposure to ambient temperatures equal to or
lower than 10
◦C is possible in temperate areas during the
winter months. Upon exposure to extremely low ambient
temperatures (those below 0◦C) skin surface temperatures
as low as 12
◦Ca n d1 8
◦C have been measured, even during
periods of activity [37, 38]. Therefore, while the cold
temperature used in this study may seem extreme for human
exposure, it is possible for skin to achieve a lower than
normal temperature in certain geographic locales.
Given the fact that substantial cold exposure occurs in
humans living in climates with cold winters and given the
plethora of mechanisms by which cooling could enhance
many of the DPN pathogenic pathways, it is perhaps not
surprising that we have found evidence for at least a subtle
eﬀect.Moreover,thermoregulatoryimpairmentinadvancing
DPN may also allow foot temperature to decrease further
than normal and for more extended periods of time. Recent
work that we have completed in human subjects supports
that such abnormalities in thermoregulatory control are
easily observed [39]. The data presented here (Figure 3(b))
support the possibility of this association in that there was
a trend for the diabetic animals exposed to cold to develop
a relatively greater reduction in foot temperature than the
nondiabetic controls exposed to cold.
Although we identiﬁed changes in H-reﬂex measure-
ments, we did not identify clear pathology in sural nerve
axon density at 20 weeks. This is not unexpected, in part,
because H-reﬂex abnormalities have been reported as a
very early indicator of DPN, even in asymptomatic patients8 Experimental Diabetes Research
[40] and similarly negative nerve pathology results have
been found in STZ-induced diabetes [41, 42]. Additionally,
we found a decrease in IENF density only in the diabetic
cold group but unexpectedly not in the diabetic room
temperature group. Although some investigators have found
a reduction in IENF in the rat STZ model of DPN,
direct comparisons to published data are diﬃcult, due to
diﬀerences in duration of diabetes and rat strain [43, 44].
Moreover, an earlier study assessing IENF density in the
foot pads of STZ-induced diabetic rats actually showed an
increase in density [45].
In this study, we assessed just a single cold temperature
range (10 ± 2◦C) and so additional studies assessing several
temperatures, including perhaps warmer ones, may be
warranted. Moreover, our choice of 23
◦C for the room
temperature cohorts may not have been ideal since that
temperature may already be considerably lower than most
animals experience regularly, given the presence of bedding
and the warmth/insulation this provides. Thus, future ani-
mal work will need to focus on the establishment of a dose-
response eﬀect with cooling, the potential eﬀects of warming
in ameliorating DPN, and, of course, more detailed studies
of the mechanisms underlying this phenomenon.
5. Conclusion
The aim of this study was to evaluate the eﬀects of
repeated cold exposure on the development of DPN in the
streptozotocin model of rat diabetes. The results of this study
indicate that such exposure in diabetic animals exacerbates
DPN, as measured by electrophysiological assessments and
epidermal nerve ﬁber density. Additionally, cold exposure in
diabetic animals leads to an increase in skin nitrotyrosine
levels, implicating reactive oxygen species formation as one
potential mechanism underlying this eﬀect. These results
suggest that limiting cold exposure of the distal extremities
in human diabetic patients may help slow onset and
progression of DPN.
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